Skip to content

upper respiratory tract infection

Evaluation Of Vyaghari Haritaki in Kaphaja Pratishyaya

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033494
Enrollment
40
Registered
2021-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J398- Other specified diseases of upperrespiratory tract

Interventions

Intervention1: Vyaghari Haritaki Awaleha: 5 to 8 year 5gm i.e. ½ tbsf twice a day, 8 to 12 year 7.5gm i.e. ¾ tbsf twice a day, 12 year 10gm i.e. 1 tbsf twice a day, oral for 21 days Control Interve

Sponsors

Dr Swabi
Lead Sponsor
Dr Swabi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of age group 5-16 years irrespective of sex, locality and socioeconomic status. 2. Patients having classical symptoms of Pratishaya i.e. Headache, Rhinorrhea, Nasal itching, Cough, Anosmia, Sneezing, Nasal congestion

Exclusion criteria

Exclusion criteria: 1. Children below 5 years and above 16 will be excluded. 2. Known case of Systemic diseases like-T.B, Pneumonia, Asthma. 3. D.N.S 4. Nasal polyps. 5. Tumors of nose. 6. LRTIs. 7. Immune deficiency disorders

Design outcomes

Primary

MeasureTime frame
Relief in symptoms like 1. Kshavathu (sneezing) 2. Kasa (cough) 3. Jwara (fever) 4. Aruchi (anorexia) 5. Shirashoola (headache) 6. Nasa avarodha (nasal obstruction) 7. Nasa shrava (Rhinorrhea) 8. Gandha Hani (Anosmia) Timepoint: 21th Day

Secondary

MeasureTime frame
Hb % TLC DLC ESR Timepoint: 21th day

Countries

India

Contacts

Public ContactDr Swabi

Asst. Professor

deepbhu10@gmail.com9013945535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026